drugset / Trial / NCT05739474
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children
RandomizedParallel-groupDouble-blindPrevention
Summary
The goal of this clinical trial is to assess tolerability, reactogenicity, safety and immunogenicity of the Flu-M Tetra vaccine as compared to the VaxigripTetra vaccine in terms of prevention of influenza in children aged 6 months to 17 years old inclusive.
Timeline
- Start
- 2022-01-19
- Primary completion
- 2023-06-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flu-M Tetra | Vaccine | 0.25 ml | Intramuscular |
| Subject | Flu-M Tetra | Vaccine | 0.5 ml | Intramuscular |
| Subject | NITRAMINE | Vaccine | 0.25 ml | Intramuscular |
| Subject | NITRAMINE | Vaccine | 0.5 ml | Intramuscular |